Every material Form 8-K abrdn World Healthcare Fund filed with the SEC in 2022, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
The fund entered a distribution agreement dated December 14, 2022, with Foreside Fund Services, allowing it to sell common shares worth up to $150 million at market prices over time. Foreside has also engaged UBS Securities as a sub-placement agent for these sales. The filing does not report any shares sold yet, but future sales could add shares outstanding and raise capital for the fund.
Up to $150 million of common shares may be offered through Foreside Fund Services as agent, from time to time.
The fund pays Foreside a 1.00% commission on gross sale proceeds; Foreside pays UBS up to 0.80% of those proceeds.
Agreements are dated December 14, 2022, under a prospectus supplement and a shelf registration on Form N-2 (File No. 333-267555).
The fund may not sell shares below current net asset value, excluding distributing commissions or discounts.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every abrdn World Healthcare Fund filing is on SEC EDGAR ↗. 8-K briefs of other companies →